title: Angiotensin II increases left ventricular mass without affecting myosin isoform mRNAs.
abstract: We studied the effect of chronic (7 days) angiotensin II (Ang II) infusion in nonpressor and pressor doses on cardiovascular mass and expression of alpha- and beta-myosin heavy chain genes in the left ventricle in normotensive Wistar rats. An increased left ventricular mass was observed in rats receiving non-pressor and pressor doses of Ang II, but only high doses increased arterial pressure. Normalization of arterial pressure during Ang II infusion by losartan, a specific Ang II receptor antagonist, or hydralazine had different effects on left ventricular mass. Losartan prevented the increased left ventricular mass, and hydralazine did not affect left ventricular mass. Northern blot analysis showed that the switch in left ventricular myosin isoform mRNA from the adult to the fetal pattern occurred only in rats given the pressor Ang II dose. Both losartan and hydralazine, in parallel with the normalization of arterial pressure, prevented this myosin isoform switch. Thus, these data suggest that the Ang II-induced increase in left ventricular mass was not dependent on pressure overload, but the switch in myosin isoform mRNA from the adult to the fetal pattern was dependent on pressure overload.
authors.affiliation: Laboratory on Hypertension Research, Alton Ochsner Medical Foundation, New Orleans, La. 70121, USA.
authors.forename: D
authors.initials: D
authors.lastname: Susic
authors.forename: E
authors.initials: E
authors.lastname: Nuñez
authors.forename: E D
authors.initials: ED
authors.lastname: Frohlich
authors.forename: O
authors.initials: O
authors.lastname: Prakash
mesh_terms: D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology*; D001713:Biphenyl Compounds / Q000494:pharmacology; D006352:Heart Ventricles / Q000187:drug effects*; D006439:Hemodynamics / Q000187:drug effects; D006830:Hydralazine / Q000494:pharmacology; D017379:Hypertrophy, Left Ventricular / Q000139:chemically induced* / Q000517:prevention & control; D007093:Imidazoles / Q000494:pharmacology; D015918:Infusion Pumps, Implantable; D019808:Losartan; D008297:Male; D018995:Myosin Heavy Chains / Q000187:drug effects* / Q000235:genetics; D009929:Organ Size / Q000187:drug effects; D012333:RNA, Messenger / Q000187:drug effects*; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D013777:Tetrazoles / Q000494:pharmacology
chemical_list: D000959:Antihypertensive Agents; D001713:Biphenyl Compounds; D007093:Imidazoles; D012333:RNA, Messenger; D013777:Tetrazoles; D000804:Angiotensin II; D006830:Hydralazine; D018995:Myosin Heavy Chains; D019808:Losartan